D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 138 Citations 76,791 461 World Ranking 1017 National Ranking 606

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Cancer

His scientific interests lie mostly in Internal medicine, Immunology, Gastroenterology, Hepatitis and Hepatitis C. His research on Internal medicine frequently connects to adjacent areas such as Endocrinology. His work on Virology expands to the thematically related Immunology.

Jay H. Hoofnagle interconnects Liver cancer and Antibody in the investigation of issues within Virology. His studies in Gastroenterology integrate themes in fields like Liver transplantation, Surgery and Biopsy, Liver biopsy, Pathology. His Hepatitis C research includes elements of Alanine transaminase and Ribavirin.

His most cited work include:

  • Classification of chronic hepatitis: diagnosis, grading and staging. (2252 citations)
  • International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis (2162 citations)
  • Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (1964 citations)

What are the main themes of his work throughout his whole career to date?

Jay H. Hoofnagle spends much of his time researching Internal medicine, Immunology, Virology, Gastroenterology and Hepatitis. Internal medicine and Endocrinology are frequently intertwined in his study. His Immunology study is mostly concerned with Hepatitis B, Hepatitis C virus, Antibody, Hepatitis C and Alpha interferon.

His Hepatitis B research integrates issues from HBeAg and Hepatitis B virus. His study focuses on the intersection of Virology and fields such as Antigen with connections in the field of Immune system. His Gastroenterology research is multidisciplinary, incorporating perspectives in Chronic hepatitis, Surgery, Liver biopsy, Liver injury and Pathology.

He most often published in these fields:

  • Internal medicine (45.01%)
  • Immunology (43.52%)
  • Virology (31.63%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (45.01%)
  • Gastroenterology (29.30%)
  • Liver injury (7.43%)

In recent papers he was focusing on the following fields of study:

Jay H. Hoofnagle focuses on Internal medicine, Gastroenterology, Liver injury, Immunology and Liver disease. His works in Prospective cohort study, Hepatology, Liver transplantation, Cirrhosis and Hepatitis C are all subjects of inquiry into Internal medicine. His work carried out in the field of Hepatitis C brings together such families of science as Ribavirin, Hepacivirus and Hepatitis C virus.

Jay H. Hoofnagle combines subjects such as Chronic hepatitis, Liver biopsy, Alkaline phosphatase and Hepatitis with his study of Gastroenterology. His Immunology study frequently links to adjacent areas such as Young adult. His study in Liver disease is interdisciplinary in nature, drawing from both Transient elastography, Nodular regenerative hyperplasia and Transplantation.

Between 2011 and 2021, his most popular works were:

  • Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study (367 citations)
  • From non-A, non-B hepatitis to hepatitis C virus cure (220 citations)
  • Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. (204 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Cancer

His primary areas of investigation include Internal medicine, Gastroenterology, Liver injury, Hepatology and Prospective cohort study. His Internal medicine research incorporates themes from Endocrinology and Immunology. His Hepatitis C, Ribavirin and Alpha interferon study in the realm of Immunology connects with subjects such as Context.

His Gastroenterology research is multidisciplinary, relying on both Biopsy, Liver biopsy, Hepatitis, Placebo and Alkaline phosphatase. His study looks at the intersection of Hepatitis and topics like Pathology with Hyperlipidemia and Statin. His Liver injury study integrates concerns from other disciplines, such as Chronic liver disease, Liver transplantation and Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi.
Journal of Hepatology (1999)

3387 Citations

Classification of chronic hepatitis: diagnosis, grading and staging.

Valeer J. Desmet;Michael Gerber;Jay H. Hoofnagle;Michael Manns.
Hepatology (1994)

3277 Citations

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough.
The New England Journal of Medicine (2010)

3126 Citations

Viral Hepatitis and Liver Disease

Girish N. Vyas;Jules Dienstag;Jay H. Hoofnagle.
(1985)

2304 Citations

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

A. M. Di Bisceglie;P. Martin;C. Kassianides;M. Lisker-Melman.
The New England Journal of Medicine (1989)

1891 Citations

THE TREATMENT OF CHRONIC VIRAL HEPATITIS

Hoofnagle Jh;di Bisceglie Am.
The New England Journal of Medicine (1997)

1416 Citations

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

Hoofnagle Jh;Mullen Kd;Jones Db;Rustgi.
The New England Journal of Medicine (1986)

1415 Citations

Overweight, obesity, and health risk.

C. J. Billington;L. H. Epstein;N. J. Goodwin;J. O. Hill.
JAMA Internal Medicine (2000)

1341 Citations

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Jordan J. Feld;Jay H. Hoofnagle.
Nature (2005)

1310 Citations

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

Liang Tj;Rehermann B;Seeff Lb;Hoofnagle Jh.
Annals of Internal Medicine (2000)

1158 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jay H. Hoofnagle

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 209

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 206

Kenji Ikeda

Kenji Ikeda

University of California, San Francisco

Publications: 172

Yoshiyuki Suzuki

Yoshiyuki Suzuki

Fukushima Medical University

Publications: 167

Yasuji Arase

Yasuji Arase

University of Yamanashi

Publications: 167

Masahiro Kobayashi

Masahiro Kobayashi

Toranomon Hospital

Publications: 153

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 149

Fumitaka Suzuki

Fumitaka Suzuki

National Taiwan University

Publications: 147

Norio Akuta

Norio Akuta

Toranomon Hospital

Publications: 139

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 138

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 135

Satoshi Saitoh

Satoshi Saitoh

Toranomon Hospital

Publications: 135

Albert J. Czaja

Albert J. Czaja

Mayo Clinic

Publications: 124

Osamu Yokosuka

Osamu Yokosuka

Chiba University

Publications: 122

Robert H. Purcell

Robert H. Purcell

National Institute of Allergy and Infectious Diseases

Publications: 120

Tetsuya Hosaka

Tetsuya Hosaka

Toranomon Hospital

Publications: 115

Trending Scientists

Pei Xu

Pei Xu

New Mexico State University

Lijian Zuo

Lijian Zuo

Zhejiang University

Elizabeth A. Croft

Elizabeth A. Croft

Monash University

Aurobinda Routray

Aurobinda Routray

Indian Institute of Technology Kharagpur

Shaoyi Jiang

Shaoyi Jiang

Cornell University

Pierre Gibart

Pierre Gibart

Centre national de la recherche scientifique, CNRS

Jian Yang

Jian Yang

Pennsylvania State University

Kin Man Yu

Kin Man Yu

City University of Hong Kong

Anu Suomalainen

Anu Suomalainen

University of Helsinki

Colomban de Vargas

Colomban de Vargas

Université Paris Cité

Roland E. Kontermann

Roland E. Kontermann

University of Stuttgart

Ad Aertsen

Ad Aertsen

University of Freiburg

Joseph H. Callicott

Joseph H. Callicott

National Institutes of Health

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Jared B. Jobe

Jared B. Jobe

National Institutes of Health

Julianne J. Dalcanton

Julianne J. Dalcanton

University of Washington

Something went wrong. Please try again later.